Director Successfully Avoids Class Action Lawsuit

A former director of a publicly traded international healthcare financing company successfully avoided charges and claims from a shareholder and bondholder. Our firm represented the director in the class action lawsuit alleging securities fraud and related claims under Sections 10(b) and 20(a) of the Exchange Act involving numerous alleged accounting irregularities, as well as the related investigations brought by the U.S. Securities and Exchange Commission and the U.S. Attorney’s Office.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.